Sapatnekar A. Conventional Synthetic Disease-modifying Drugs Remain the Mainstay of Therapy for Rheumatoid Arthritis in India. JDAI [Internet]. 2025 May 2 [cited 2025 Jul. 17];1(1). Available from: https://journals.onemd.in/index.php/jdai/article/view/59